Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in participants with advanced non-small cell lung cancer completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. [Phase 1]
This Phase I trial evaluated vorinostat in combination with docetaxel in patients with advanced and relapsed solid malignancies, including n…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial evaluates erlotinib hydrochloride alone or in combination with cabozantinib-s-malate as second- or third-line therapy for…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluated Imprime PGG in combination with cetuximab and paclitaxel/carboplatin for untreated advanced non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating stereotactic body radiotherapy in combination with rhGM-CSF and thymosin alpha-1 for stage IV non-small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy [Phase 2]
Phase 2 clinical trial update examining the combination of radiotherapy and thymosin in metastatic non-small cell lung cancer patients who h…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports on safety, tolerability, pharmacokinetics and anti-tumor activity of AC0010 in advanced Non-Small Cell Lu…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
A post-marketing surveillance study of docetaxel-based chemotherapy in non-small cell lung cancer and head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC [Phase 2]
A Phase 2 clinical trial update evaluating high-dose icotinib beyond progression in patients with EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery [Phase 1]
A Phase 1 study evaluating azacitidine and entinostat in newly diagnosed stage IA-IIIA non-small cell lung cancer patients undergoing surger…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study evaluated everolimus as monotherapy in patients with advanced non-small cell lung cancer. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating icotinib in non-small cell lung cancer patients with uncommon EGFR m…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 trial evaluating Avastin (bevacizumab) in non-squamous non-small cell lung cancer has completed. The document notes the trial stat…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. [Phase 1]
Phase 1 study of Avastin (bevacizumab) in combination with thoracic radiation and chemotherapy in patients with advanced non-squamous non-sm…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating safety and pharmacology of the PI3-kinase inhibitor pictilisib (GDC-0941) in combination with chemotherapy regimens…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 3]
Phase 3 study evaluating Onartuzumab with Erlotinib in MET-positive, EGFR-mutant non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and pharmacology of GDC-0941 in combination with erlotinib in patients with advanced solid tumors, inclu…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer [Phase 2]
The document reports the completion of a Phase 2 exploratory trial evaluating RO4929097 in patients with recurrent or refractory non-squamou…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) [Phase 3]
A Phase 3 clinical trial evaluating onartuzumab in combination with erlotinib (Tarceva) in patients with Met diagnostic-positive non-small c…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
The PEPITA observational study evaluating erlotinib (Tarceva) in second-line squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)
An observational study evaluating lung cancer-related symptoms and disease-control rate in patients with non-squamous non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. [Phase 2]
A genetic substudy associated with Roche's Avastin trial MO19390 in advanced or recurrent non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer. [Phase 1]
Phase 1 feasibility trial evaluating Avastin (bevacizumab) with concomitant chemoradiation (cisplatin and vinorelbine) for locally advanced …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
This update covers a completed observational study evaluating erlotinib (Tarceva) in previously treated patients with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …